The TCR-based therapy market is projected to grow at an annualized rate of 51%, claims Roots Analysis
Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various disease indications
For additional details, please visit https://www.rootsanalysis.com/....reports/tcr-based-th or email sales@rootsanalysis.com
![image](https://morda.eu/upload/photos/2023/01/feTyCSithN5doDXr5cKA_20_a8254555036580d0380b616896065337_image.png)